Anti-rejection drugs are expected to no longer accompany lifelong new research or can be solved

scientists have been looking for ways to get the body to use foreign organs as its ownImmunosuppressive drugs that block organ rejection were widely used in the 1980s, but they increase the risk of cancer, kidney failure and many other problems, and can cause unpleasant side effects such as excessive hair growth, bloating and tremorsHowever, U.Sdoctors have developed a new technique that could make it possible for many patients who receive organ transplants to take anti-rejection drugs for lifeThe treatment involves weakening the patient's immune system and then infusion of the bone marrow cells of the donorA study by DrDavid Sachs of the Massachusetts GeneralHospital in Boston, Usa
1990s, showed that the treatment worked on a patient with a kidney transplant with a higher genetic matchThe woman underwent an organ and bone marrow transplant in 1998 and has not been required to take anti-rejection drugs ever sinceThe new study, which involved five patients who received kidneys from their parents or siblings, and donor organ tissue that did not match the donor's organ tissue during organ transplant surgery, offered hope that more people might not have to take anti-rejection drugs in the futureIn the treatment, Sachs used intravenous drugs to weaken the patient's immune system a few days before the transplant, which infuses the patient with the donor's bone marrow to create a new immune system in which stem cells in the bone marrow allow new immune cells to grow that do not attack the transplanted organThe patient was initially given anti-rejection drugs, but stopped after a few months